Double-blind comparison of iodamide and diatrizoate for excretory urography.
A double-blind comparison of meglumine iodamide and Renografin 60 (52% meglumine diatrizoate and 8% sodium diatrizoate) for bolus excretory urography was performed. Doses of 0.8 cc/kg. to a maximum of 55 cc were administered to fifty patients, twenty-five receiving each drug.There is a suggestion that iodamide may be superior to diatrizoate in pyelocalyceal opacification while being equal to diatrizoate in parenchymal opacification and in types and severity of side-effects.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003973:Diatrizoate / Q000031:analogs & derivatives*; D003974:Diatrizoate Meglumine / Q000009:adverse effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007451:Iodamide / Q000009:adverse effects; D007463:Iodobenzoates; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014567:Urography
D007463:Iodobenzoates; D003973:Diatrizoate; D003974:Diatrizoate Meglumine; D007451:Iodamide